These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23815871)

  • 1. Epidemiology of complementary and alternative medicine use in patients with Parkinson's disease.
    Wang Y; Xie CL; Wang WW; Lu L; Fu DL; Wang XT; Zheng GQ
    J Clin Neurosci; 2013 Aug; 20(8):1062-7. PubMed ID: 23815871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson's disease at a neurological outpatient clinic.
    Lökk J; Nilsson M
    Parkinsonism Relat Disord; 2010 Sep; 16(8):540-4. PubMed ID: 20655794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of complementary and alternative therapies in outpatients with Parkinson's disease in Argentina.
    Pecci C; Rivas MJ; Moretti CM; Raina G; Ramirez CZ; Díaz S; Uribe Roca C; Micheli FE
    Mov Disord; 2010 Oct; 25(13):2094-8. PubMed ID: 20721921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of alternative therapies by patients with Parkinson's disease.
    Rajendran PR; Thompson RE; Reich SG
    Neurology; 2001 Sep; 57(5):790-4. PubMed ID: 11552005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of complementary and alternative medicine by Korean patients with Parkinson's disease.
    Kim SR; Lee TY; Kim MS; Lee MC; Chung SJ
    Clin Neurol Neurosurg; 2009 Feb; 111(2):156-60. PubMed ID: 18977584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
    Swarup AB; Barrett W; Jazieh AR
    Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medications consumed by renal patients in southern Germany.
    Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
    J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
    Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
    Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.
    Ashikaga T; Bosompra K; O'Brien P; Nelson L
    Support Care Cancer; 2002 Oct; 10(7):542-8. PubMed ID: 12324809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of complementary and alternative medicine use in chronic pain patients.
    Ndao-Brumblay SK; Green CR
    Pain Med; 2010 Jan; 11(1):16-24. PubMed ID: 20447293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complementary and alternative medicine by patients seen at the dermatology department of a tertiary care center.
    Kalaaji AN; Wahner-Roedler DL; Sood A; Chon TY; Loehrer LL; Cha SS; Bauer BA
    Complement Ther Clin Pract; 2012 Feb; 18(1):49-53. PubMed ID: 22196574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional and complementary therapies in Parkinson's disease.
    Manyam BV; Sánchez-Ramos JR
    Adv Neurol; 1999; 80():565-74. PubMed ID: 10410773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine (CAM) among hospitalised patients: an Australian study.
    Shorofi SA; Arbon P
    Complement Ther Clin Pract; 2010 May; 16(2):86-91. PubMed ID: 20347839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience.
    Naing A; Stephen SK; Frenkel M; Chandhasin C; Hong DS; Lei X; Falchook G; Wheler JJ; Fu S; Kurzrock R
    Cancer; 2011 Nov; 117(22):5142-50. PubMed ID: 21538342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Professional ethics in complementary and alternative medicines in management of Parkinson's disease.
    Kim HJ; Jeon B; Chung SJ
    J Parkinsons Dis; 2016 Oct; 6(4):675-683. PubMed ID: 27589539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.
    Shorofi SA
    Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.
    Olsen SA
    Occup Ther Int; 2009; 16(1):57-70. PubMed ID: 19222053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer.
    Lengacher CA; Bennett MP; Kipp KE; Berarducci A; Cox CE
    Oncol Nurs Forum; 2003; 30(5):811-21. PubMed ID: 12949594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage of and cost of complementary/alternative medicine in diabetic patients.
    Moolasarn S; Sripa S; Kuessirikiet V; Sutawee K; Huasary J; Chaisila C; Chechom N; Sankan S
    J Med Assoc Thai; 2005 Nov; 88(11):1630-7. PubMed ID: 16471112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.